News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
723,770 Results
Type
Article (44097)
Company Profile (308)
Press Release (679365)
Section
Business (212298)
Career Advice (2183)
Deals (37094)
Drug Delivery (114)
Drug Development (84191)
Employer Resources (177)
FDA (16697)
Job Trends (15579)
News (359842)
Policy (34410)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (6)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (6)
2025 BioForest Digital (5)
2025 Lone Star Bio Digital (6)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2626)
Accelerated approval (2)
Adcomms (26)
Allergies (85)
Alliances (52015)
ALS (89)
Alzheimer's disease (1390)
Antibody-drug conjugate (ADC) (127)
Approvals (16684)
Artificial intelligence (254)
Autoimmune disease (21)
Automation (14)
Bankruptcy (377)
Best Places to Work (11854)
BIOSECURE Act (20)
Biosimilars (113)
Biotechnology (193)
Bladder cancer (59)
Brain cancer (26)
Breast cancer (255)
Cancer (2078)
Cardiovascular disease (179)
Career advice (1816)
Career pathing (32)
CAR-T (147)
Cell therapy (411)
Cervical cancer (19)
Clinical research (68203)
Collaboration (807)
Compensation (467)
Complete response letters (28)
COVID-19 (2676)
CRISPR (41)
C-suite (219)
Cystic fibrosis (101)
Data (1987)
Decentralized trials (2)
Denatured (27)
Depression (43)
Diabetes (263)
Diagnostics (6450)
Digital health (17)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (116)
Drug pricing (116)
Drug shortages (31)
Duchenne muscular dystrophy (88)
Earnings (88351)
Editorial (35)
Employer branding (21)
Employer resources (152)
Events (115799)
Executive appointments (667)
FDA (17833)
Featured Employer (51)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (709)
Gene editing (105)
Generative AI (23)
Gene therapy (299)
GLP-1 (769)
Government (4575)
Grass and pollen (4)
Guidances (48)
Healthcare (19146)
Huntington's disease (23)
IgA nephropathy (25)
Immunology and inflammation (119)
Indications (27)
Infectious disease (2817)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (47)
Intellectual property (89)
Interviews (340)
IPO (16927)
IRA (48)
Job creations (4162)
Job search strategy (1555)
Kidney cancer (10)
Labor market (34)
Layoffs (495)
Leadership (20)
Legal (8519)
Liver cancer (71)
Lung cancer (303)
Lymphoma (137)
Machine learning (4)
Management (61)
Manufacturing (288)
MASH (65)
Medical device (13460)
Medtech (13465)
Mergers & acquisitions (20644)
Metabolic disorders (698)
Multiple sclerosis (75)
NASH (20)
Neurodegenerative disease (90)
Neuropsychiatric disorders (30)
Neuroscience (1902)
NextGen: Class of 2025 (6728)
Non-profit (4553)
Northern California (2448)
Now hiring (37)
Obesity (383)
Opinion (245)
Ovarian cancer (74)
Pain (88)
Pancreatic cancer (77)
Parkinson's disease (141)
Partnered (20)
Patents (214)
Patient recruitment (94)
Peanut (50)
People (59608)
Pharmaceutical (98)
Pharmacy benefit managers (21)
Phase I (21251)
Phase II (29967)
Phase III (22450)
Pipeline (1069)
Podcasts (87)
Policy (131)
Postmarket research (2685)
Preclinical (8939)
Press Release (68)
Prostate cancer (96)
Psychedelics (31)
Radiopharmaceuticals (253)
Rare diseases (383)
Real estate (6360)
Recruiting (67)
Regulatory (23356)
Reports (46)
Research institute (2392)
Resumes & cover letters (370)
Rett syndrome (3)
RNA editing (4)
RSV (45)
Schizophrenia (73)
Series A (123)
Series B (81)
Service/supplier (13)
Sickle cell disease (54)
Southern California (2119)
Special edition (17)
Spinal muscular atrophy (153)
Sponsored (29)
Startups (3790)
State (2)
Stomach cancer (15)
Supply chain (64)
The Weekly (58)
United States (21597)
Vaccines (692)
Venture capitalists (37)
Webinars (12)
Weight loss (276)
Women's health (34)
Worklife (16)
Date
Today (146)
Last 7 days (745)
Last 30 days (2854)
Last 365 days (34496)
2025 (8380)
2024 (36162)
2023 (40938)
2022 (52119)
2021 (56675)
2020 (55111)
2019 (47831)
2018 (36142)
2017 (33574)
2016 (33172)
2015 (39015)
2014 (32966)
2013 (28086)
2012 (30170)
2011 (30873)
2010 (28890)
Location
Africa (809)
Alabama (49)
Alaska (7)
Arizona (233)
Arkansas (14)
Asia (41585)
Australia (6609)
California (5599)
Canada (1890)
China (497)
Colorado (250)
Connecticut (258)
Delaware (133)
Europe (89068)
Florida (837)
Georgia (194)
Idaho (57)
Illinois (515)
India (24)
Indiana (305)
Iowa (9)
Japan (146)
Kansas (100)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (850)
Massachusetts (4261)
Michigan (211)
Minnesota (374)
Mississippi (2)
Missouri (77)
Montana (27)
Nebraska (25)
Nevada (57)
New Hampshire (62)
New Jersey (1614)
New Mexico (31)
New York (1608)
North Carolina (972)
North Dakota (7)
Northern California (2448)
Ohio (194)
Oklahoma (14)
Oregon (39)
Pennsylvania (1269)
Puerto Rico (10)
Rhode Island (26)
South America (1182)
South Carolina (18)
South Dakota (1)
Southern California (2119)
Tennessee (94)
Texas (842)
Utah (168)
Virginia (139)
Washington D.C. (58)
Washington State (522)
West Virginia (3)
Wisconsin (51)
723,770 Results for "evoke pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Evoke Pharma, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 14, 2025
·
15 min read
Press Releases
Evoke Pharma Announces the Appointment of Greg Pyszczymuka to the Board of Directors
February 24, 2025
·
5 min read
Press Releases
Evoke Pharma to Report Fourth Quarter and Full Year 2024 Results on March 13, 2025
March 6, 2025
·
3 min read
Press Releases
Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results
November 8, 2024
·
12 min read
Biotech Beach
Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI
Evoke Pharma, Inc., a specialty pharmaceutical company focused primarily on treatments for gastrointestinal diseases with an emphasis on GIMOTI® nasal spray, announced updates regarding their business and commercial growth strategy.
June 17, 2024
·
9 min read
Business
Evoke Pharma Reports First Quarter 2024 Financial Results
Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today announced its financial results for the first quarter ended March 31, 2024, and recent corporate developments.
May 14, 2024
·
11 min read
Press Releases
Evoke Pharma Highlights GIMOTI as a Leading Solution for Gastroparesis Treatment as Domperidone Supply Ends
December 20, 2024
·
9 min read
Press Releases
Evoke Pharma, Inc. Supports Gastroparesis Awareness Month
August 8, 2024
·
10 min read
Biotech Beach
Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis
Evoke Pharma, Inc. announced it will host a virtual KOL and investor webinar on Wednesday, April 24 at 12:00 p.m. ET.
April 17, 2024
·
5 min read
Press Releases
Evoke Pharma, Inc. Announces Reverse Stock Split
July 30, 2024
·
5 min read
1 of 72,377
Next